Clinical Trials Browser

Breast Neoplasms, Neoplasm Metastasis, Disease Progression

NCT06635447 2026-01-13

CAPItrue

Phase 3 Recruiting

300 enrolled

Breast

Breast Neoplasms, Disease Progression

NCT04987203 2025-08-22

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Phase 3 Active not recruiting

343 enrolled

Genitourinary

Carcinoma, Renal Cell, Disease Progression

NCT07008716 2025-06-06

Omitting CTV for Primary Tumor in LS-SCLC

Phase 3 Recruiting

852 enrolled

Radiation Injuries, Disease Progression

NCT02761070 2023-03-08

RE-GEND

Phase 3 Unknown

146 enrolled

CNS

Glioblastoma, Recurrence, Disease Progression

NCT01109004 2021-12-09

BMT CTN 0702

Phase 3 Completed

758 enrolled 21 charts

Plasma cell

Hematologic Diseases, Multiple Myeloma, Disease Progression

NCT02322320 2020-05-11

Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)

Phase 3 Completed

273 enrolled 16 charts

Plasma cell

Hematologic Diseases, Multiple Myeloma, Disease Progression

NCT01191060 2019-04-18

IFM/DFCI2009

Phase 3 Completed

700 enrolled

Plasma cell

Disease Progression, Neoplasms, Plasma Cell

NCT00171925 2012-04-11

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I

Phase 3 Terminated

143 enrolled 10 charts

Plasma cell

Multiple Myeloma, Disease Progression

Clinical Trials

CAPIcorn

CAPItrue

Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma

Omitting CTV for Primary Tumor in LS-SCLC

RE-GEND

BMT CTN 0702

Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)

IFM/DFCI2009

Therapy With Zoledronic Acid in Patients With Multiple Myeloma Stage I